Stocksigma LogoStocksigma Logo

Balaji Amines Receives FDA Warning Letter Over Product End-Use; No Financial Impact

The Food & Drug Administration, Pune, issued a Directions and Warning Letter dated 10th Jan'25 to Balaji Amines after a customer unauthorizedly resold its

Balaji Amines Receives FDA Warning Letter Over Product End-Use; No Financial Impact

Balaji Amines Ltd 路 Others (Uncategorized) 路 01 Oct 2026, 5:45 pm

Balaji Amines Receives FDA Warning Letter Over Product End-Use; No Financial Impact The Food & Drug Administration, Pune, issued a Directions and Warning Letter dated 10th Jan'25 to Balaji Amines after a customer unauthorizedly resold its technical-grade Propylene Glycol for pharmaceutical use, violating the Drugs and Cosmetics Act, 1940. No penalties, prosecution, or adverse orders were levied against the company. Balaji Amines stated there is no material impact on financials or operations and has updated documentation practices by mandating end-use declarations. The disclosure follows a SEBI directive dated 29th Sep'26.

Original exchange filing (PDF)

More announcements from Balaji Amines Ltd

All Balaji Amines Ltd announcements